NeuroSense Therapeutics Ltd. (NRSN)
Market Closed
26 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
2. 38
-0.08
-3.252%
After Hours
$
+0.49 +20.5882% 2. 87
4.67M Market Cap
- P/E Ratio
- Div Yield
1,093 Volume
-0.8 Eps
$ 2.46
Previous Close Want to track NRSN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NeuroSense Therapeutics Ltd. (NRSN) Statistics
Valuation metrics
Market Cap 4.67M
Enterprise value 4.67M
Trailing P/E (ttm) -0.35
Forward P/E -
PEG ratio -0.09
Price/Sales (ttm) -
Price/Book (mrq) -2.02
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.54
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 28.1K
Average volume (90 days) 25.04K
Price summary
52-Week low 2.15
52-Week high 25.4
Beta -
50-Day moving average 5.13
200-Day moving average 9.61
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 14 Sep 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -8.53%
Return on equity 7.23%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -6.86
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.13
Total debt (mrq) -
Total Debt/Equity (mrq) -0.11
Current ratio (mrq) 0.31%
Book value per share (mrq) -1.22
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
